Recombinant protein production (RPP) is a cornerstone of bioprocessing. This study presents novel analytical techniques and production protocols for RPP in E. coli, particularly regarding industrial applications. Flow cytometry (FCM) was used to monitor cell physiology and RPP during production of a fluorescent model protein, CheY::GFP. Further applications of FCM for monitoring RPP were developed: The amyloidophilic dye Congo red was used to identify inclusion bodies produced under high-stress conditions. FCM analysis of transformants on agar plates identified 3 populations of varying fluorescence intensity and the progressive transfer of cells from the high fluorescence population to one of intermediate fluorescence and low culturability...
As high-level recombinant protein production (RPP) exerts a massive stress on the production host, a...
The demand for therapeutic recombinant proteins is set to see a significant increase over the next f...
Escherichia coli expression systems remain a preferred choice for the production of recombinant prot...
Many biopharmaceutical projects require the production of recombinant protein in a bacterial host. C...
Many biopharmaceutical projects require the production of recombinant protein in a bacterial host. C...
The demand for therapeutic recombinant proteins is set to see a significant increase over the next f...
The demand for therapeutic recombinant proteins is set to see a significant increase over the next f...
The demand for therapeutic recombinant proteins is set to see a significant increase over the next f...
A C-terminal green fluorescent protein (GFP) fusion to a model target protein, Escherichia coli CheY...
The demand for therapeutic recombinant proteins is set to see a significant increase over the next f...
The demand for therapeutic recombinant proteins is set to see a significant increase over the next f...
As high-level recombinant protein production (RPP) exerts a massive stress on the production host, a...
As high-level recombinant protein production (RPP) exerts a massive stress on the production host, a...
As high-level recombinant protein production (RPP) exerts a massive stress on the production host, a...
This work presents an evaluation of the applicability of gene reporter technology to monitor Escheri...
As high-level recombinant protein production (RPP) exerts a massive stress on the production host, a...
The demand for therapeutic recombinant proteins is set to see a significant increase over the next f...
Escherichia coli expression systems remain a preferred choice for the production of recombinant prot...
Many biopharmaceutical projects require the production of recombinant protein in a bacterial host. C...
Many biopharmaceutical projects require the production of recombinant protein in a bacterial host. C...
The demand for therapeutic recombinant proteins is set to see a significant increase over the next f...
The demand for therapeutic recombinant proteins is set to see a significant increase over the next f...
The demand for therapeutic recombinant proteins is set to see a significant increase over the next f...
A C-terminal green fluorescent protein (GFP) fusion to a model target protein, Escherichia coli CheY...
The demand for therapeutic recombinant proteins is set to see a significant increase over the next f...
The demand for therapeutic recombinant proteins is set to see a significant increase over the next f...
As high-level recombinant protein production (RPP) exerts a massive stress on the production host, a...
As high-level recombinant protein production (RPP) exerts a massive stress on the production host, a...
As high-level recombinant protein production (RPP) exerts a massive stress on the production host, a...
This work presents an evaluation of the applicability of gene reporter technology to monitor Escheri...
As high-level recombinant protein production (RPP) exerts a massive stress on the production host, a...
The demand for therapeutic recombinant proteins is set to see a significant increase over the next f...
Escherichia coli expression systems remain a preferred choice for the production of recombinant prot...